Monthly series cohosted by DBMI and OTD

The Biomedical Informatics Entrepreneurs Salon (BIES), which the department cohosts with Harvard University's Office of Technology Development, meets monthly 4:30–6:30 pm in the Waterhouse Room of Gordon Hall at HMS to promote entrepreneurship at the convergence of biology, medicine, and computing. In addition to hearing industry leaders speak, participants will have the chance to look for collaborators, employees, advisors, customers, or investors. Bring your ideas, get some pizza!

BIES is open to everyone. Tickets are free but limited, and registration is required.

Join our mailing list to receive invitations to future events.

Upcoming

6/12/19 (Wednesday)
Scott Barclay
Partner, DCVC
Register

9/24/19 (Tuesday)
Andy Coravos
Co-founder and CEO, Elektra Labs
Register

10/29/19 (Tuesday)
Jamie Band
Tiger Management
Register


Past

5/7/19

  • Michael E. Zalis, Chief, Clinical Solutions and Strategy, One Brave Idea; Radiologist, Massachusetts General Hospital

4/10/19

  • Tom Knight, Founder, Ginkgo Bioworks

3/7/19

  • Krishna Yeshwant, General Partner, GV

2/7/19

  • Kurt Rohloff, Co-Founder, CTO, Duality Technologies;
    Alexander "Sasha" Gusev, Faculty, Dana-Farber Cancer Institute, Harvard Medical School

12/18/18

  • Gail H. Javitt, Member of the Firm, Epstein Becker Green

11/28/18

  • Peter Lee, Corporate Vice President for AI and Research, Microsoft Healthcare, EY Parthenon

9/17/18

  • Kristin Pothier, Global Head of Life Sciences, EY Parthenon

5/3/18

  • Sumita Pennathur, Professor of Mechanical Engineering, University of California Santa Barbara

4/17/18

  • John S. Brownstein, Chief Innovation Officer, Boston Children's Hospital; Professor of Biomedical Informatics, Harvard Medical School

3/5/18

  • Roman Yelensky, Executive Vice President and Chief Technology Officer, Gritstone Oncology

11/30/17

  • Lisa Suennen, Managing Director, GE Ventures

10/30/17

  • Dr. David Botstein, Chief Scientific Officer, Calico

9/15/17

  • Rich Gliklich, General Catalyst Ventures, OM1, Inc.

5/24/17

  • Colin Hill, GNS Healthcare

4/26/17

  • Jonathan Bush, athenahealth

3/29/17

  • Jennifer Chayes, Microsoft Research

2-22-2017

  • Will Crawford, Vice President of Engineering at Fitbit

1-25-2017

  • D. Levin Brown, MD, MPH; CEO, FleetHealth

11-7-2016

  • David Shaywitz, M.D., Ph.D., CMO, DNAnexus, and Visiting Scientist, Dept. Biomedical Informatics, HMS

9-19-2016

  • David De Graaf, PhD, CEO, Syntimmune

6-16-2016

  • Chris Colbert, MBA, Director of Programming at Harvard i-Lab
  • Dan Gebremedhin MD, MBA, Senior Associate, Flare Capital Partners

5-26-2016

  • Roz Picard, Sc.D., IEEE Fellow, Professor, MIT Media Lab, and founder of Empatica

4-21-2016

  • David Altshuler, M.D., Ph.D., Executive Vice President, Global Research and Chief Scientific Officer, at Vertex
  • Luba Greenwood, JD, Vice President, Global Mergers & Acquisitions and Business Development, at Roche

3-24-2016 Photo Gallery

  • Aman Bhandari, PhD, Executive Director of Data Science & Insights at Merck
  • John Boyce, CEO Exosome Diagnostics, former CEO of GnuBIO